These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10864286)

  • 21. Death but one unintended consequence of gene-therapy trial.
    Sibbald B
    CMAJ; 2001 May; 164(11):1612. PubMed ID: 11402803
    [No Abstract]   [Full Text] [Related]  

  • 22. Why were NIH adverse event reporting guidelines misunderstood?
    Finn R
    J Natl Cancer Inst; 2000 May; 92(10):784-6. PubMed ID: 10814665
    [No Abstract]   [Full Text] [Related]  

  • 23. RAC ponders its purpose: to be or not to be.
    Jenks S
    J Natl Cancer Inst; 1993 Oct; 85(19):1544-6. PubMed ID: 8411224
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical gene transfer: adverse event reporting fully harmonized.
    Woo S
    Mol Ther; 2002 Aug; 6(2):140. PubMed ID: 12161178
    [No Abstract]   [Full Text] [Related]  

  • 25. US gene therapy in crisis.
    Teichler Zallen D
    Trends Genet; 2000 Jun; 16(6):272-5. PubMed ID: 10827455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIH recombinant DNA Advisory Committee continues to ponder adverse event associated with AAV gene therapy trial.
    Williams DA
    Mol Ther; 2008 Mar; 16(3):427-8. PubMed ID: 18297091
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials end at gene-therapy institute..
    Smaglik P
    Nature; 2000 Jun; 405(6786):497. PubMed ID: 10850679
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene therapy's new era: a balance of unequivocal benefit and unequivocal harm.
    Friedmann T
    Mol Ther; 2003 Jul; 8(1):5-7. PubMed ID: 12872762
    [No Abstract]   [Full Text] [Related]  

  • 29. Altering the pathway to human gene therapy.
    Lewis ME
    Clin Genet; 2000 Jul; 58(1):12-5. PubMed ID: 10945655
    [No Abstract]   [Full Text] [Related]  

  • 30. Plus ça change..
    Friedmann T
    Mol Ther; 2003 Nov; 8(5):701. PubMed ID: 14632022
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory issues for clinical gene therapy trials.
    Cornetta K; Smith FO
    Hum Gene Ther; 2002 Jul; 13(10):1143-9. PubMed ID: 12133267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy death--"everyone has to share in the guilt".
    Jenks S
    J Natl Cancer Inst; 2000 Jan; 92(2):98-100. PubMed ID: 10639505
    [No Abstract]   [Full Text] [Related]  

  • 33. Crossing the research valleys of death: the University of Pittsburgh approach.
    Reis SE; McDonald MC; Byers SJ
    Clin Transl Sci; 2008 May; 1(1):9-10. PubMed ID: 19412329
    [No Abstract]   [Full Text] [Related]  

  • 34. US drive to speed trials for rare disorders.
    Wadman M
    Nature; 1998 Sep; 395(6697):4. PubMed ID: 9738483
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene therapy under cloud.
    Lancet; 2000 Jan; 355(9201):329. PubMed ID: 10665545
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy review finds few complications.
    Jenks S
    J Natl Cancer Inst; 1993 Aug; 85(15):1188-90. PubMed ID: 8331676
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene therapy for the public.
    Nature; 1999 Dec; 402(6763):703. PubMed ID: 10617178
    [No Abstract]   [Full Text] [Related]  

  • 38. U.S., researchers reach deal in '99 gene therapy case.
    Weiss R
    Washington Post; 2005 Feb; ():A3. PubMed ID: 15742518
    [No Abstract]   [Full Text] [Related]  

  • 39. Arthritis gene therapy's first death.
    Evans CH; Ghivizzani SC; Robbins PD
    Arthritis Res Ther; 2008; 10(3):110. PubMed ID: 18510784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings of the National Conference on Clinical Trials Methodology.
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):629-766. PubMed ID: 35299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.